Tuesday, 31 October 2017

Pathology Imaging Systems Market to Record Study Growth by 2027

Pathology imaging system uses the latest technology of scanners and software for digitizing the slides for pathological examinations. It has replaced the traditional pathology workflow of slides and microscope. By digitizing slides, pathologists are able to examine high resolution digital images of the pathology workflow with the help of precision tools. Using these system, images can be stored in a computer, send to another person and thus improve the pathology workflow. This technology helps in more precise diagnosis by facilitating accurate and timely diagnosis, patient-centric information, eliminate time consuming analog tasks and enhancing the overall lab performance. These systems helped the patients to receive better care and transforming healthcare organizations. With the growing cases of chronic diseases like cancer, it has become important to visualize each and every molecular aspect. Pathology imaging systems have finds its use in all the phases of drug discovery, education, clinical and research and thus has made the anatomic pathology workflow more efficient and effective.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4125

These pathology imaging systems are instinctive solution that benefits various pathologists, healthcare professionals and entire healthcare enterprise. Shift from glass to the digital system opens the way for next generation tools such as advanced image analysis & algorithms. It also helps in new data integration like genomic and molecular testing thus leading to precise and personalized treatment plans.
Pathology Imaging Systems Market: Drivers & Restraints
Rising cancer incidences, increasing demand of improved diagnostic techniques, increasing spending on healthcare, government funding, rising R&D efforts are some of the factors driving the overall market of pathology imaging systems. Popularity of pathology imaging systems in hospitals, diagnostic centers and research organizations are surging the market. Rise in the tele-pathology trend also fuels the market growth. High capital investment and maintenance cost curbs the growth. Less number of highly skilled operators, stringent regulatory compliance, sampling error also limits its expansion.
Pathology Imaging Systems Market: Segmentation
 Segmentation by Product Type
  • Imaging Systems
  • Accessories and software
  • Services
Segmentation by Application
  • Clinical Diagnosis
  • Academic Research
Segmentation by End Users
  • Hospitals
  • Diagnostic Laboratories
  • Research Organizations
Pathology Imaging Systems Market: Overview
A large number of key players in the market and established brands increasing the competition. New technologies in this sector are cutting edge for the market. Strategic mergers and partnerships between companies and academic institutions are also booming the growth. Significant technology gains led to the adoption of innovative imaging systems technology in pathology. Rising demand by various end users because of increasing adoption of this technology increases its market. Diagnosis applications is accounted to be the largest segment in terms of revenue generating.
Pathology Imaging Systems Market: Region-wise Outlook
With high technological advancements, and research activities in the molecular diagnostics, North America dominates the world market followed by Western European nations. Quality diagnostics, favourable reimbursement scenario, government funding, established players in the market, availability of trained technicians in these regions creates the established market for pathology imaging systems. . Japan is expected to be the next lucrative market for digital pathology companies. With respect to growth rate, Asia Pacific is leading because of growing economies, increasing molecular research activities, increasing patient pool and improving healthcare opportunities.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-4125

Pathology Imaging Systems Market: Key Players

Some of the key players for Pathology Imaging Systems Market include GE Healthcare, Leica Biosystems, Perkin Elmer, Siemens, Olympus Corporation, Philips Healthcare, Sakura Finetek, DigiPath, Carl Zeiss Meditec AG, Hamamatsu Photonics, 3D-Histech Ltd and others.

Super Generics Market Growth to be Driven by Technological Advancements 2027

The generics market is very competitive with several companies looking to develop newer versions of generics by adding value to the product which helps in getting the market exclusivity extension for particular brand. Large cost of drug development and time overrun for developing new therapeutic entities, hindering innovation in pharmaceutical research and developing space there by promoting the companies to look for alternatives to sustain the patent protection of the given brand. Super generics or improved therapeutic entities are the superior form of the given generic molecule which has better patient compliance and therapeutic effect than already existing generic versions. Manufacturers adopt the quality by design, uses multifunctional excipients, modifies the dosage form and release pattern to develop value added generics i.e. super generics which create new segment of growth and assure better quality and economic viability to the payors.
A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4126
Super Generics Market: Drivers and Restraints
Global super generics market is expected to grow at significant rate owing to lack of innovation from pharmaceutical companies, increased cost of new drug development and added advantage of extended market exclusivity for improved version of super generic product. The factors currently contributing to the revenue growth of the super generics market is requirement of less time and cost of development, improved therapeutic effect, patient compliance and improved access or affordability of the treatment due to economic viability. Furthermore, increased market opportunities for generics, expected patent expiries over forecast period and increasing awareness about generics among key stakeholders are expected to drive the market for super generics over the forecast period.
Global super generics market may hindered by availability of low cost generics from developing markets and price pressure from payers which are expected to affect the market negatively over the forecast period. The super generics market is restrained by pay for delays by innovator companies, commoditization of generic market, and misuse of Risk Evaluation and Mitigation Strategies (REMS) programs by innovator companies to withhold access to drug samples for generic manufacturers’ bioequivalence testing and development, which are expected to hinder market revenue growth of super generics over the forecast period
Super Generics Market: Segmentation
Global super generics market has been segmented on the basis of products type, route of administration, distribution channel, and Region
Based on the producttype, the global super generics market is segmented into the following:
  • Drugs
  • Biologics
Based on the route of administration, the global super generics market is segmented into the following:
  • Oral
  • Injectable
  • Topical
  • Others
Based on the distribution channel, the global super generics market is segmented into the following:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
Super Generics Market: Overview
Global Super Generics market is witnessing significant changes due to recent patent expiries across the globe. Several patented blockbuster drugs set to expire in next few years. Several pharmaceutical companies developing improved version of me to drugs which could help gain larger market share in the pharmaceutical market space. Several tier-2 pharmaceutical companies are dependent upon these super generics to gain regulatory approval in developed economies there by gain market exclusivity for the improved therapeutic entities. Sometimes players need to file New Drug Application (NDA) to get market approval for super generics.
Super Generics Market: Region-wise Outlook
Geographically, super generics market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Western Europe will remain key markets for super generics products due to attractive pharmaceutical market size and conducive regulatory environment which aims to decrease diseases treatment costs, all these factors together helps to maintain larger market revenue share in the globalsuper generics market by these regions. Asia Pacific is anticipated to present better growth opportunity owing to presence of key manufactures, who concentrate on incremental innovation and coupled with rising healthcare investment and spending in the region.
Super Generics Market: Key Players
Some of the players in the global super generics market are Sun Pharmaceutical Industries Ltd., Meda Pharmaceuticals Inc., Taiwan Liposome Company, Dr. Reddy’s Laboratories Ltd., Allergan plc., Teva Pharmaceutical Industries Ltd., and Celgene Corporation to name a few.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-4126


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Personalized Orthopaedic Implant Market to Register Substantial Expansion by 2027

Orthopaedics implant is a medical device used for the replacement of missing joints, bones and or to support a damaged bones. The orthopaedics implants are mainly manufactured using biomaterials and coated by plastic. The personalized orthopaedics implants are known as custom made implants as the implants market is getting more personal and advanced with the increasing demand of patient specific implants. In personalized orthopaedics implants, new technology is playing a vital role such as 3D imaging and modeling and digital manufacturing. A planned surgical model accompanies the production steps such as designing to the made to measure prosthesis. The contract manufacturers and specialized digital manufacturing technologies drivers the growth of the personalized orthopaedics implant market.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4127

The recent trend such as adapting the implant to the patient instead of adapting patient to the implant, to minimize the failure rate in orthopaedics operatives helping market to grow over a forecast period.
The global personalized orthopaedics implant market is segmented on the basis of product type, solution delivery type, solution type and end user.
  • On the basis of product type, the global personalized orthopaedics Implant market is segmented into:
    • Internal Fixation Devices
    • External Fixation Devices
  • On the basis of biomaterial type, the global personalized orthopaedics Implant market is segmented into:
    • Metallic
    • Ceramics
    • Polymers
    • Others
  • On the basis of anatomical location, the global personalized orthopaedics implant market is segmented into:
    • Hip
    • Knee
    • Foot and ankle
    • Spine
    • Shoulder
    • Elbow
    • Others
  • On the basis of end users, the global personalized orthopaedics implant market is segmented into:
    • Hospitals
    • Orthopaedics Clinics
    • Ambulatory Surgical Centers
    • Others
The global personalized orthopaedics implant market is anticipated to register a significant CAGR over a forecast period. The rapidly growing geriatric population and increasing prevalence of the associated disorders such as osteoarthritis, osteoporosis, disc diseases, hip pain, knee pain, and low-bone density is anticipated to boost the demand of the personalized orthopaedics implants and drives the market. The increasing prevalence of sports related bone injuries also leads to the increasing demand of the orthopaedics implants and expected to boost the growth of the global personalized orthopaedics implants market. The increasing research and development activities and the availability of the customized implants as per the need of the case, which foster the demand of the orthopaedics implants and drives the global personalized orthopaedics implants market over a forecast period. The rising accidental cases resulted to the bone injuries and also anticipated to propel the growth of the global personalized orthopaedics implant market on a long run.
However, the high cost of personalized orthopaedics implants may hamper the demand of the implants and restrain the growth of the global personalized orthopaedics implant market. The stringent and non-favorable reimbursement coverage policies and the possible adverse effects of post-surgery infections, hypersensitivity, implant dislocation and toxic issues of implants may slow down the demand and hinder the growth of the global personalized orthopaedics implant market over the forecast period.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-4127

On the basis of regional presence, the global personalized orthopaedics market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global personalized orthopaedics implant market in terms of value and anticipated to register a significant CAGR over a forecast period. The Europe is also contributing the moderate shares to the market due to the advanced medical facilities and easy availability of the personalized orthopaedics implant in the market. APAC is the most lucrative market for the personalized orthopaedics implant due to the increasing acceptance of advanced surgical procedures and developing medical infrastructure in the region and expected to show a robust growth to the global personalized orthopaedics implant market. MEA is at a nascent stage to the global personalized orthopaedics implant market and anticipated to register a decent growth to the market over a forecast period. Overall, the global personalized orthopaedics implant market is expected to show significant growth over a forecast period.

Arteriovenous Fistula Treatment Market Intelligence with Competitive Landscape 2027

Arteriovenous fistula is also known as abnormal connection between and artery and vein. As we know blood flow from a set pattern to reach tissue, as blood flow from artery to capillaries to veins. The blood work as a carrier in the human body for supply of nutrients and oxygen and also carry the impure blood. Arteriovenous fistula is disorder in which blood flow bypassed the pattern and directly flows from artery into vein, this bypass flow effect the tissue present below the capillaries and receive a mixed blood. This occurs in legs, arms, kidneys but can also occur in any place of the body. The causes for arteriovenous fistula is injuries that pierce the skin, genetic conditions, by born and others. The symptoms for arteriovenous fistula is swelling in legs or arms, fatigue, heart failure, and bulging of veins that can view through the skins.  The complication occurs due to arteriovenous fistula is blood clots, leg pain and bleeding.
A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4128
Arteriovenous Fistula Treatment Market: Drivers and Restraints
Arteriovenous fistulas treatment market is a growing market over the forecast period, the players are coming with new treatment methods is photodynamic therapy, antiangiogenic therapy and other method of sclerotherapy. The effective treatment method for complete cure in an easy way is still under development process, which initiate the players to come up with new innovations for the treatment. The awareness is a hindrances for arteriovenous fistula.
Arteriovenous Fistula Treatment Market: Segmentation
Arteriovenous fistula treatment segmentation is based on
Based on Type
  • Arteriovenous fistulas
  • Dural arteriovenous fistulas
  • Peripheral arteriovenous fistulas
  • Pial or cerebral arteriovenous fistulas
  • Others
Based on Treatment Type
  • Drugs
  • Transcatheter Embolization
  • Ultrasound-guided Compression
  • Surgery
Arteriovenous Fistula Treatment Market: Overview
The market of arteriovenous fistula treatment is having a huge potential for growth as the treatment methods are limited and the number of population effect is high, this will directly affect the market for growth. The arteriovenous fistula treatment methods are in research to come-up in the market.
Arteriovenous Fistula Treatment Market: Region-wise Outlook
Geographically, Arteriovenous Fistula Treatment Market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America have a huge potential as major pharmaceutical players are placed in that region, Europe and Asia Pacific are the growing region where the awareness have to create for the market.
Arteriovenous Fistula Treatment Market: Key Players
Some of the players in Arteriovenous Fistula Treatment Market include: Becton Dickinson, and Company, Medtronic, B. Braun Melsungen Ag, Cook Medical, Teleflex Incorporated, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Inc. and Poly Medicure Limited
To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-4128

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Endoscope Protective Barrier Covers Market Growth to be Driven by Technological Advancements 2027

The endoscope protective barrier covers act as a shielding fence to the endoscope, mainly prevents from cross-contamination and the spread of dangerous microorganisms. These endoscope covers have the properties of flexibility and antimicrobial protective mechanism. Endoscope covers are totally sterile, a product with an integrated working channel between the patient and the endoscope. The disposable endoscope protective barrier comprises of an operative channel for suction, irrigation, and tool passageway, doctors may use the covers during a full range of therapeutic & diagnostic procedures. The endoscope cover is available in numerous functioning channel sizes, letting the physician to acclimatize the possibility to fit the diagnostic procedure. By using the endoscope barrier cover, it eliminates the need for conventional high-level disinfection/sterilization routines between each procedure. Instead, the physician get a safe, sterile protective barrier for each patient and rapid equipment turnaround for the practice. The endoscope protective barrier covers market has evolved gradually and comprises of different varieties of sizes used during endoscopy procedures. The market is anticipated to grow with fastest CAGR due to increase in the endoscopy diagnostic and therapeutic procedures coupled with few cases with cross contamination in the U.S. and Europe.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5183

Endoscope Protective Barriers Covers Market: Drivers & Restraints
The primary factor for the growth of global endoscope protective barrier covers market is the increasing number of hospital admissions coupled with endoscopy related procedures. New innovation in endoscope covers, e.g. EndoSheath protective barrier (manufactured by Cogentix Medical) eliminates the difficult-to-clean channel which exists in conventional endoscopes, newly manufactured endoscope protective barrier covers are now offered in several models, each with a diverse size working channel. Few advantages include: endoscope protective barrier covers changes the paradigm of endoscope handling and reprocessing procedures, slays the challenges of scouring and flushing endoscope channels to ensure organic content is expelled from the two exterior and inside the device. Staff and medical device exposure to harsh chemicals are decreased, expanding both staff security and equipment lifespan. Simple to utilize and get ready; restricts the intricacy of endoscope preparation. Endoscopes can be set up without the multifaceted nature, tedious and botch inclined regular HLD/Sterilization schedules. Secondly growing healthcare expenditure levels and the introduction of advanced technologiesin endoscope protective barriers covers acts as a driver during the forecast period. Also increase in the number of new product launches also the drives the revenue growth of endoscope protective barrier covers market. However incidences of cross contamination, less follow up of new guidelines, untrained professionals in the endoscopy practice and less availability of products in the emerging markets may act as a restraint during the forecast period.
Endoscope Protective Barriers Covers Market: Segmentation
This market is segmented on the basis of tip flexibility, coating, material and end user
Segmentation based on applications
  • ENT endoscopes
  • Flexible endoscopes
  • Others
Segmentation based on end user
  • Hospitals
  • ASCs
  • Specialty Clinics
Availability of advanced treatment options coupled with endoscopy procedures, also drives the demand for endoscope protective barrier covers over the forecast period. However presence of different types of covers or sheaths provides good number of options to the surgeons for selecting a sheath for endoscopy procedures which in turn drives the market for endoscope protective barrier covers over the forecast period.
Endoscope Protective Barriers Covers Market: Overview
Depending on geographic region, the Endoscope protective barriers covers market is segmented into seven key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Globally, endoscope protective barriers covers market is expected to witness healthy growth in the near future. North America is expected to hold major share of global endoscope protective barriers covers market followed by Western Europe owing to technological advancement, increasing number of players in endoscope protective barriers covers market and increasing awareness regarding endoscopy related procedures. Also it has been analyzed that endoscope protective barriers covers have been widely adopted in clinical practice and is associated with improved clinical outcomes in Western Europe.
Endoscope Protective Barriers Covers Market: Key Players
Some of the key market players in endoscope protective barrier covers market includes Cogentix Medical,  Cover Srl, etc. these players are entering into mergers & acquisitions, strategic collaborations, and product portfolio expansions, distribution agreements which are their key sustainability strategies. Secondly many local players have started entering in this lucrative market.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-5183


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

Computer Assisted Anesthesia Systems Market Intelligence with Competitive Landscape 2027

Digital surgical methods have transformed significantly due to the introduction of the computer assisted technology systems. One such method is computer assisted anesthesia systems. Computer assisted anesthesia systems now incorporates dynamic pressure sensing technology coupled with tailored flow rate with each injection type. The digital platform controls flow rate and pressure of local anesthesia during an injection. It is significantly more comfortable than the syringe, greatly reduces anxiety and can eliminate collateral numbness. With the introduction of computer assisted anesthesia systems system surgeons can pre-plan the surgical procedure prior to the actual process and perform a more accurate surgery. The technology can customize procedures according to each patient's individual anatomy. During the surgery, the physician has to do the real work, but computer assisted anesthesia systems system guides the surgeon’s tools according to the predetermined method to place the injection safely and accurately in the exact pre-planned locations.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5182

Computer Assisted Anesthesia Systems Market: Drivers and Restraints
Hospital cost reduction through decreased length of stay in hospital and aging of the population are the key driving factors for computer assisted anesthesia systems market. Top manufacturers provide new computer assisted anesthesia systems that redefine the worldwide standard of care for injection techniques by making the experience more comfortable for the patient and by reducing the anxiety and stress of administering injections for the healthcare provider. Computer assisted anesthesia systems has been proven successful in administering medicaments into the intra-articular space using its computer-controlled pressure sensing capabilities. This eliminates the need to use a manual syringe to locate the intra-articular space and leaves less room for error while injecting the appropriate volume of medicament. Repeatability and reliability associated with the computer assisted anesthesia systems are also making this method of surgery popular among physicians. Computer assisted anesthesia systems dramatically improves how medical and dental professionals administer injections. For patients, these medical devices make the experience much less stressful and virtually pain-free. Top features include: a virtually painless experience for all injections, eliminates disruptive injection behavior, site-specific targeting, and controlled needle exit-pressure precise flow rate and drug volumes coupled with superior ergonomics. Rising hospital admissions and potential of digital surgical platforms to increase the effectiveness of existing surgical procedures are also the growth driving factors for computer assisted anesthesia systems market.
Computer Assisted Anesthesia Systems Market: Segmentation
The global computer assisted anesthesia systems market has been segmented on the basis of application, surgery type, end users, and region.
Based on application global computer assisted anesthesia systems market can be segmented into:
  • Medical Specialties
    • Anesthesiology
    • Orthopedic Surgery
    • Pain Medicine
    • Physical Medicine/Rehabilitation
    • Primary Care/Urgent Care
    • Rheumatology
    • Sports Medicine
  • Dental Specialties
  • Others
Based on surgery type global computer assisted anesthesia systems market can be segmented into:
  • Open Surgery
  • Minimal Invasive
Based on end users global computer assisted anesthesia systems market can be segmented into:
  • Hospitals
  • Clinics
  •  Ambulatory Surgical Centers
  • Others
Computer Assisted Anesthesia Systems Market: Overview
Computer assisted anesthesia systems market is expected to show significant growth due to the factors such as increasing rate of surgical procedures, technology assessment, and new product launch with digital platforms associated with surgery. Substantial cost savings in terms of pre- and post-operative care and decreased length of stay at hospitals are also major factors responsible for computer assisted anesthesia systems market growth. Dynamic pressure sensing technology, controlled needle exit-pressure, precise flow rate and drug volumes and others are the major applications of computer assisted anesthesia systems system. The ability of these methods with digital platforms are expected to account for its high market share. 
Computer Assisted Anesthesia Systems Market: Region wise outlook
Geographically, computer assisted anesthesia systems market is segmented into, North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. North Americas region is expected to be biggest market for computer assisted anesthesia systems mainly because of the high standards of surgical procedures and innovation by the key market players. Followed by which is Europe. Asia-Pacific region is expected to be the fastest growing market for the computer assisted anesthesia systems attributed to increasing awareness among physicians and people regarding the treatment of spinal disorder with high accuracy and safety and increasing adoption of robots for surgical procedures by healthcare organizations. 
Computer Assisted Anesthesia Systems Market: Key Market Participants
Some of the market participants in the global computer assisted anesthesia systems market are WandDental, Inc., Milestone Scientific, Inc., Evident etc. These companies are mainly focusing on innovation and acquisition strategies.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-5182


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

Retrovirus Testing Market Intelligence with Competitive Landscape 2027

Retrovirus is a single stranded RNA virus that is composed of an enzyme called reverse transcriptase. With the help of reverse transcriptase, retroviral RNA gets transcribed into retroviral DNA once it enters into a host cell. The retrovirus then allows integration of its retroviral DNA into chromosomal DNA of host cell. This integration facilitates the replication of retrovirus into the host genome, thereby leading to its expression. The most common type of retrovirus known in humans is HIV (Human Immunodeficiency Virus). Other type of retrovirus causing infection in humans include Human T-cell Lymphotropic Virus 1 (HTLV-1), Human T-cell Lymphotropic Virus 2 (HTLV-2), HIV 1, HIV 2, and others. As retrovirus acts as a causative agent for a variety of life-threatening diseases such as HIV-AIDS, it has to be diagnosed in time and proper treatment should be given in order to treat this life-threatening infection. A wide range of diagnostic tests are available in the market to screen retrovirus. The major type of diagnostic tests for detection of retrovirus includes assays and immunological tests such as infectivity assay, Product-enhanced reverse transcriptase (PERT) assay, Co-cultivation assay, Transmission Electron Microscopy (TEM), rapid diagnostic tests and thus contribute majorly to the revenue generation in retrovirus testing market. Radioimmunoassay and Western blot analysis are other majorly utilized testing methods for detection of retrovirus. Infectivity assays are further classified as direct focus assays and extended assays in which initial cell line is used to amplify the retrovirus. Also, retrovirus testing is performed using advanced techniques such as PCR based amplification, high-throughput screening, non-radioactive ELISA and others. In addition with blood and serum samples, cells and body fluids are other sample forms used to perform sensitive detection of retrovirus in the suspected genome. The retrovirus detection tests are usually applied on three main stages of a manufacturing process that consists of Master Cell Bank, End of Production (EOP) cell banks and Bulk Harvest. The most common type of retrovirus assay performed to detect infectious retrovirus present in CHO cell lines is Mink or Feline S+L- assay. However, Product Enhanced Reverse Transcriptase (PERT) assay is carried out for detection of infectious retrovirus in the human cell lines. Retrovirus testing find vast applications in early stage diagnosis of various life-threatening infectious disease which increases the demand in retrovirus testing market. The increasing usage of retrovirus testing generates large revenues in the retrovirus testing market owing to their increased demand in hospitals and diagnostic laboratories. On the other hand, retrovirus testing market is gaining profit due to rising incidence of HIV–infectious diseases, STDs and rising expenditure in research across the globe. Increasing adoption of in-vitro assays to detect retrovirus infection in human system tends to propel the growth of retrovirus testing market over the globe and registers a significant revenue growth in the retrovirus testing market.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5181

Retrovirus Testing: Market Dynamics
Increasing capability of retrovirus tests to provide quick results enabling instant treatment decisions, high availability of high-end retrovirus screening instruments, assays and kits coupled with being efficient diagnostic tool for retrovirus testing are some of the major factors expected to drive the growth of retrovirus testing market. Introduction of rapid and technologically advanced retroviral infection detection technologies, growing awareness about diagnostic tests and increased expenditure in retrovirus screening R&D is further propelling the growth of retrovirus testing market. Also, rise in demand for retrovirus testing in the hospitals and diagnostic laboratories is also expected to drive the growth of retrovirus testing market. However, lack of trained people to perform sensitive assays associated with retrovirus testing and high cost of assays and diagnostic kits are some of the factors restraining the retrovirus testing market growth.
Retrovirus Testing Market: Segmentation
The global retrovirus testing market is segmented by test type, technique type, sample type and end user:
Segmentation by Test Type
  • Infectivity Assay
  • Product-Enhanced Reverse Transcriptase (PERT) Assay
  • Co-Cultivation Assay
  • Transmission Electron Microscopy
  • Radio-Immuno Assay
  • Western Blot Analysis
  • Immunofluorescence
  • Serological Tests
Segmentation by Technique Type
  • High-Throughput Screening
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
Segmentation by Sample Type
  • Blood
  • Serum
  • Body Fluids
  • Cells
Segmentation by End User
  • Hospitals
  • Clinics
  • Diagnostic Laboratories and Centers
Retrovirus Testing Market: Overview
Based on product type, infectivity assays are most commonly used methods for retrovirus testing in the retrovirus testing market owing to the rapid and accurate results obtained from these assays. Retrovirus testing is majorly done using high-throughput technique and PCR based amplification for sensitive detection of retrovirus infection in the target genome. The diagnostic labs segment in end user is expected to register largest revenue shares in retrovirus testing market owing to the increased entry of outpatient samples for retroviral testing in early diagnosis of HIV-AIDS, thereby fueling the retrovirus testing market over the globe.
Retrovirus Testing Market: Region-wise Outlook
On the basis of geography, global retrovirus testing market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold largest shares in the global retrovirus testing market primarily due to growing R&D activities to detect retrovirus infection in the human body at early stages. North America is followed by Europe which registers second largest shares in global retrovirus testing market worldwide. However, Asia Pacific is expected to experience a robust growth over the forecast period and generates high revenues in global retrovirus testing market.
Retrovirus Testing Market: Key Players
Some of the key players present in global retrovirus testing market are Abbott Diagnostics, Alere Inc., Roche Diagnostics Ltd., DiaSorin S.p.A., bioMérieux SA, Becton, Dickinson and Company and others.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-5181


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

Intraoperative Radiation Therapy Systems Market Plan, Supply and Revenue to 2027

Intraoperative radiation therapy systems (IORT) used to destroy the microscopic tumor cells after surgery, intraoperative radiation therapy delivers a concentrated dose of radiation to a tumor site immediately after a tumor is removed. Because of differential radiation or intrabeam properties, the spectrum is used to identify the microbial composition inside the cells. IORT is the application of therapeutic stages of radiation to the tumor site. IORT is regularly a segment in the multidisciplinary treatment of privately progressed and repetitive disease, in the mix with outer beam radiation, chemotherapy, and surgery. As a developing pattern as of late, IORT can likewise be utilized as a part of prior stage diseases, for example, breast cancer growth and prostate cancer. Few advantages of IORT includes: IORT can deliver maximum effect with a comparable dose of radiation in a single treatment session, IORT Spares healthy tissues and other surrounding organs, also IORT helps in reducing the treatment period within a very short span of time. Intraoperative radiation therapy systems minimizes procedural complications and also prevent further complications while taking radiation therapies in future. It is considered to be boost for traditional radiation patients after they have recovered from the surgical procedure after the whole treatment cycle.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5180

Intraoperative Radiation Therapy Systems Market: Drivers and Restraints
Increasing incidence of cancer (prostate cancer, breast cancer and others) along with the lifestyle patterns and growing matured population drives the intraoperative radiation therapy systems market. Traditionally available intraoperative radiation therapy systems have fundamental limitations that do not allow complete and detailed evaluation of tumor cells. Because of these limitations, the risk of cancer or other malignancy related issues is rising. But newly available radiation techniques enable accurate assessment of cancer cell characteristics, and reliable identification of cancerous cells. Along with these, increasing demand due to limited manufacturers for intraoperative radiation therapy systems drives the market.  Increasing morbidity and mortality due to a cancer is also another factor driving towards the rapid advancement of technology. All these factors are contributing to the robust growth of the intraoperative radiation therapy systems market. In the IORT treatment procedure, by using low energy x-rays radiation can be given with a high dose (for e.g. radiation with intrabeam), exactly into the tumor or unswervingly subsequently resection to the tumor bed, driving the overall growth of the market. The advanced products from top manufacturers empowers an individual treatment ensuring that skin and more profound structures are ensured and a shorter length of the radiation treatment contrasted with external beam radiation therapy treatment. Lack of consciousness about the intraoperative radiation therapy systems, cost structure and IORT systems does not get full-scale acceptances among the physicians and healthcare professionals due to ease of use, which acts as a restraint on the growth of the market. Intraoperative radiation therapy systems still considered as a novel technology for which reimbursements are not available completely which act as a restraint to the overall growth of the market.
Intraoperative radiation therapy systems Market: Segmentation
Segmentation based on Disease Indication:
  • Brain Tumors
  • Breast Cancer
  • Gastrointestinal Tumors
  • Head & Neck Tumors
  • Skin Cancer
  • Spinal Metastases
  • Others
Segmentation based on End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory & Surgical Centers
  • Others
Intraoperative radiation therapy systems Market: Market Overview
Intraoperative radiation therapy systems market has observed a burgeoning growth due to preventive measures of healthcare systems and governments.The companies are mainly focusing on compliance with environmental laws and regulations of medical devices even though it could be expensive because failure to comply with these laws and regulations could subject to the significant liability of intraoperative radiation therapy systems. R&D efforts are focused mainly on improving on this system and investing in clinical studies to further demonstrate the effectiveness of intraoperative radiation therapy systems over the available traditional systems. Because intraoperative radiation therapy systems is new technology, many companies are focusing on extensive sales force and marketing. The future is expected with double CAGR during the forecast period.
Intraoperative radiation therapy systems Market: Region-Wise Overview
The global intraoperative radiation therapy systems market segmented into following regions North America, Western Europe, Eastern Europe, Asia-Pacific, Japan and the Middle East and Africa; Latin America. North America is dominating in the global market due to the high presence of key players. Mainly the US occupies the significant share in North America due to increased awareness and reports for breast cancer incidences. It is followed by the Europe and Asia-pacific regions due to increased acceptance of the intraoperative radiation therapy systems. The growth in the Middle East and Africa is low when compared to the developing countries due to less availability and acceptability of this systems.
Intraoperative radiation therapy systems Market: Key Participants
The key participants in the intraoperative radiation therapy systems market are Carl Zeiss Meditec AG, IntraOp Medical, Inc. iCAD, Inc. etc. The companies are mainly focusing on the strong line of distribution channels and marketing to increase the awareness about the intraoperative radiation therapy systems. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-5180


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

Contact Lens Inspection Equipment Market Growth to be Driven by Technological Advancements 2027

Automated contact lens inspection systems which consists of suitable light source, camera and image processing algorithms, for contact lenses defect inspection are gaining traction in terms of market growth owing to its ability to review the contact lens at production line with higher accuracy. The newly introduced software programs coupled with automated contract lens inspection systems are providing an user friendly platform with higher test versatility. In addition, in-house programs developed to cater the specific requirements is anticipate to fuel the growth of customized lens inspection systems. The automatic contact lens inspection systems are mostly preferable used in soft contact lens inspections.

A sample of this report is available upon request @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5179

Ophthalmic product manufacturers have grown significantly from last few years in terms of research and development. Industrial inspection is a crucial part of manufacturing process for ophthalmic devices.  Contact lenses are produced by injecting monomer solution in to the mold and then separated from the mold after cured in the oven. Contact lenses shows number of manufacturing defects due to mechanical nature of separation form the mold and defects in molding process. Hence, the manufactured contract lens needs to be inspected for material safety, visual inspection for color, lens diameter, optical zone diameter, base curve radius, power, thickness, edge quality, performance testing before released in the market for sale. The inspection of all above parameters require lengthy time on production line environment.  As results, the ophthalmic product manufacturers have introduced an automated system which is used for contact lens inspection.
Contact Lens Inspection Equipment Market: Drivers and Restraints
Increasing demand for stable lens making process, proper handling of contact lenses during manufacturing process is promoting the growth of contact lens inspection equipment market. Automated contact lens inspection equipment have promoted controlled volume manufacturing process with minimum error rate. This has resulted increasing product (contract lens) quality with lesser production time. However, high maintenance cost and scare availability of spare parts especially in automated contact lens inspection equipment are expected to hinder the growth of contract lens inspection equipment market over the forecast period. Further, the higher cost of software and customized inspection equipment hampers the adoption of contact lens inspection equipment across small scale manufacturers.
Contact Lens Inspection Equipment Market: Segmentation
Tentatively, global contact lens inspection equipment market has been segmented on the basis of product type, modality, end user and geography.
Based on product type, global contact lens inspection equipment market is segmented as below:
  • Manual Contact Lens Inspection Tool
  • Semiautomatic Contact Lens Inspection Systems
  • Fully Automatic Contact Lens Inspection Systems
Based on application, global contact lens inspection equipment market is segmented as below:
  • Disposable Contact Lens Inspection
  • Contact Lens Inside Plastic Container
  • Contact Lens Inside Molding
  • Dry Lens in the Shell
  • Color Contact Lens
  • Contact Lens Packaging Inspection
  • Others
Contact Lens Inspection Equipment Market: Overview
Inspection of contact lenses at each point of manufacturing process is crucial requirement from manufacturer perspective. Contact lenses are examined under magnification for anomalies and other manufacturing defects. Automated contract lens inspection equipment comes handy in manufacturing process, as these equipment promote in line inspection with higher accuracy. Moreover, these equipment are capable of catering customized need of the manufacturers which provide more flexibility as compared to semi-automatic and inspection systems. Such machine vision inspection solutions are reducing human interventions in contact lens manufacturing operations which is providing tract to contact lens inspection equipment market.

To view TOC of this report is available upon request @
https://www.futuremarketinsights.com/toc/rep-gb-5179

Contact Lens Inspection Equipment Market: Regional Outlook

Geographically, global contact lens inspection equipment market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America clearly dominates the global contact lens inspection equipment market due to strong investment in vision care industry led by contact lenses with more than 20% market share the in United States. Further, the commercial launches of new soft contact lens and enhancing physician training are likely to provide boost for contact lens manufacturing in Europe region. This results in increasing for contact lenses which will significantly enhance the need of Contact Lens Inspection Equipment in the region. The growing investment from small scale contact lens manufacturers in Asia Pacific region are expected to boost the growth of Contact Lens Inspection Equipment in Asia region.

Primary Biliary Cholangitis (PBC) Treatment Market Intelligence with Competitive Landscape 2027

Primary biliary cholangitis is also referred as primary biliary cirrhosis, is an autoimmune disease of liver that manifest into progressive cholestasis and lead to end-stage liver disease. Primary biliary cholangitis characterized by destruction of bile duct which transport the bile acid. Primary biliary cholangitis is detected in the late stage of disease. Primary biliary cirrhosis majorly seen in women’s in fourth or sixth decades of life. Primary biliary cholangitis generally diagnosed during routine blood examination which presents symptoms like fatigue, pertussis, and right upper quadrant discomfort. In initial examination finding the disease is normal, as the disease advances present symptoms of liver cirrhosis. The hallmark of primary biliary cirrhosis is the presence of antimitochondrial antibodies (AMAs) in the blood. Medical management of primary biliary cirrhosis mainly done to slow the symptom progression and to alleviate the symptoms.
A sample of this report is available upon request @ 

www.futuremarketinsights.com/reports/sample/rep-gb-3773 

Primary Biliary Cholangitis Treatment Market: Drivers and Restraints 

Global primary biliary cholangitis treatment market is expected to drive by highly unmet medical need owing lack of definitive treatment, advanced diagnostic process coupled rising awareness among healthcare professionals and patients alike across the globe. The Incidence and prevalence of primary biliary cholangitis vary geographically, ranging from 0.7 to 49 and 6.7 to 402 per million, respectively. The factors currently contributing to the revenue growth of the primary biliary cholangitis treatment market is increasing incidence and prevalence of the disease, increased exposure to environmental triggers to immune system such as pesticides. Furthermore, lifestyle changes like smoking, alcoholism, and obesity are expected to drive the market for primary biliary cholangitis treatment over the forecast period. 

Global primary biliary cholangitis treatment market hindered by the lack of definitive treatment for the disease and late diagnosis of the disease led to treatment deprivation to the patient. The market restrained by dearth of epidemiology data which helps to assess the product access and availability in various geographies which are expected to hinder market revenue growth of primary biliary cholangitis treatment over the forecast period 

Primary Biliary Cholangitis Treatment Market: Segmentation 

Global primary biliary cholangitis treatment market has been segmented on the basis of treatment type, end user and Region. 

Based on the treatmenttype, the global primary biliary cholangitis treatment market is segmented into the following: 

For Treatment 

Ursodeoxycholic acid 

Obeticholic Acid 

Methotrexate 

Corticosteroids 

Others 

For Symptom Control 

Antihistamines 

Cholestyramine 

Antibacterials 

Opioid Antagonists 

Colestipol 

Others 

Based on the end user, the global primary biliary cholangitis treatment market is segmented into the following: 

Hospital Pharmacies 

Retail Pharmacies 

Online Pharmacies 

Primary Biliary Cholangitis Treatment Market: Overview 

Global primary biliary cholangitis treatment market is witnessing significant changes due to recent approval of UDCA by several regulatory authorities across the globe. In May 2016, the FDA approved obeticholic acid in combination with UDCA for primary biliary cholangitis (PBC) in adult patients with an inadequate response to UDCA. U.K’s NICE (National Institute for Health and Care Excellence) and European Commission granted the market authorization for Ocaliva (obeticholic acid) form Intercept Pharmaceuticals, Inc. in the year 2017 and 2016 respectively. 

Primary Biliary Cholangitis Treatment Market: Region-wise Outlook 

Geographically, Primary biliary cholangitis treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Western Europe will remain key markets for primary biliary cholangitis treatment products due to increased regulatory approvals for treatment options, increasing awareness among patient advocacy groups regarding primary biliary cholangitis helps to maintain larger market share in the globalprimary biliary cholangitis treatment market by the regions. Asia Pacific is anticipated to present better growth opportunity owing to large untapped market, increasing out of pocket expenditure, and growing government’s interventions for improving healthcare infrastructure in the region. 

Primary Biliary Cholangitis Treatment Market: Key Players 

Some of the players in the global primary biliary cholangitis treatment market are Intercept Pharmaceuticals, Inc., Actavis, Inc., Teva Pharmaceuticals Inc., Epic Pharma, LLC, Mylan Pharmaceuticals Inc., and Axcan Scandipharm Inc. to name a few. 

To view TOC of this report is available upon request @ 

www.futuremarketinsights.com/toc/rep-gb-3773 

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Monday, 30 October 2017

Internet of Things for Diabetes Market Analysis, Segments, Growth and Value Chain -2025

Internet of Things comprises systems and software, medical devices, and services. It has had a significant impact on the overall health care sector and has been beneficial in remote clinical monitoring, chronic disease management, preventive care, assisted living, and personal fitness monitoring. The Internet of Things has transformed the health care sector by lowering costs, improving efficiency, and bringing the focus back to quality patient care. The demand for Internet of Things for diabetes is increasing with growing prevalence of diabetes, rising health concern, ease of use, technological advancements such as mobile devices and apps, and increasing adoption of smartphones and Internet services. The Internet of Things for diabetes allows individuals to track and monitor diabetes by their own, reduces doctor/physician visits, and provides results on the mobile devices immediately.

A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32435

The prevalence rate of diabetes is increasing globally with a higher rate of diabetes-related complications such as blindness, kidney failure, heart attack, stroke, and lower limb amputation. According to the World Health Organization (WHO), the number of people with diabetes increased from 108 million in 1980 to 422 million in 2014. In 2012, about 2.2 million deaths were attributable to high blood glucose; and in 2015, globally an estimated 1.6 million deaths were directly caused by diabetes. According to the World Diabetes Foundation, by 2030, an approximately 438 million people are likely to be suffering from diabetes. The global health care expenditure of about 11.6% is held by diabetes care. Presently, there are about 528.7 million people suffering from obesity, which is a key factor triggering diabetes in people.
Technological advancement and increasing connected medical devices for diabetes such as blood glucose monitoring, insulin delivery, and other glucose testing devices are expected to propel the growth of the Internet of Things for diabetes market during the forecast period. In addition, high obesity rate, dietary habits, and inactive lifestyle are other factors that have led to the increase in the demand for the Internet of Things products for diabetes. However, the reimbursement issue is a primary factor, which is limiting the market growth during the forecast period.
The global market for Internet of Things for diabetes has been segmented by component, connectivity technology, end-user, and region. In terms of component, the global market has been categorized into medical devices, systems and software (apps), and services. Based on connectivity technology, the market has been segmented into Wi-Fi, zigbee, near field communication (NFC), and others. In terms of end-user, the market has been segmented into physicians and public/private health care institutions.
Geographically, the Internet of Things for diabetes market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold a significant share of the market in terms of revenue during the forecast period due to growing demand and adoption of technologically advanced products and increasing product availability of prediabetes and diabetes care programs. Europe is estimated to be the second largest market in the near future owing to enhanced digitization of health care processes and implementation of telehealth. Asia Pacific is expected to expand at a high CAGR during the forecast period due to growing prevalence of diabetes. According to Asian Diabetes Prevention Initiative, 60% of diabetics in the world live in Asia. By 2030, without intervention, both China and India combined are projected to have nearly half a billion diabetics.
Major players operating in the Internet of Things for diabetes market include Alien Technology, Ascensia Diabetes Care Holdings AG, Johnson & Johnson, Telcare, Inc., WellDoc, Inc., Proteus Digital Health, Inc., Diabetizer Ltd. & Co. KG, GlySens, Inc., Entra Health Systems LLC, and Dexcom, Inc.

To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=32435

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis
The regional analysis covers:
  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

Arteriotomy Closure Devices Market Volume Forecast and Value Chain Analysis -2025

Vascular closure devices are required for the procedures following catherization to achieve hemostasis of the small hole created in the artery. Arterial closure devices (ACDs) are the most preferred vascular closure devices introduced in 1995 to reduce bed rest, time, pain, and discomfort associated with the mechanical compression technique. This helps in reduction of vascular complications and also decreases the time to hemostasis and ambulation. Mechanical compression technique was considered the gold standard before the introduction of vascular closure devices. Vascular closure devices are widely used in diagnostic and interventional procedures due to advantages such as reduced hemostasis and ambulation and increased patient comfort over the mechanical compression technique.

A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29861

An arterial closure device (ACD) along with a deployment tool comprises an arterial closure system. ACD is deployed within the contacting site vessel with the help of deployment tool. Arterial closure devices (ACDs) are of two types: active closure devices and passive closure devices. Active closure devices include suture devices, collagen plug devices, and clips. Passive closure devices are helpful for providing mechanical compression with enhanced hemostasis. These include hemostasis pads and compression devices such as FemoStop, Boomerang, Safeguard, Chito-Seal, and D-Stat.
Increasing geriatric population due to advancement in health care techniques, rising need of endovascular procedures, reduced complications with the use of ACDs, reimbursement of diagnostic procedures involved, and comfort to the patients are the factors driving the arterial closure devices (ACDs) market. However, less adoption in developing countries, increased cost of implantable arterial devices, and high incidence of leg ischemia are the factors restraining the market.
The arteriotomy closure devices (ACDs) market has been segmented based on type of device, application, and region. In terms of type of device, the market has been segmented into passive closure devices and active closure devices. Passive closure devices include devices that assist in the mechanism of compression such as clamps/tamping devices, assisted coagulation, and sealants. Active closure devices include devices involved in immediate closure including collagen plug, sutures, polyglycolic acid devices, and extravascular clips. Collagen plug devices can be further categorized into angioseal and vasoseal. In terms of application, ACDs can be segmented to be used for procedures carried out by femoral arterial access and for procedures carried out by transradial arterial access. Femoral arterial access is the most widely used technique; however, increased interest in transradial arterial access has been observed as it reduces bleeding complications.
Geographically, the global ACDs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the leading market for arteriotomy closure devices due to advancement in technology, involvement of diagnostic technique as reimbursement and increase in the need of vascular procedures. However, the ACDs market in some developing countries in Asia Pacific and Africa are likely to witness sluggish growth due to lack of health care advancements and adoption of complicated expensive techniques.
Key market players in the arteriotomy closure devices market include Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, and Scion BioMedical.

To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29861

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis
The regional analysis covers:
  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

Antigen Kit Market size and Key Trends in terms of volume and value -2025

Antigens are used for the production of antibodies. These can be toxins or other substances, which induce an immune response in the body. Antigens are also known as antibodies. These are microbes such as bacteria, parasites, fungi, and other antigen such as pollen. Antigen kits are used to detect antigen of various diseases such as malaria, dengue, and influenza. Antigen test kits are primarily used in rapid medical diagnostics, in vitro diagnostic devices, and molecular diagnostics. Antibodies can be measured and detected from blood sample and saliva. Some antibody tests are useful to detect past infections or to diagnose a persisting infection.

A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29843

The global antigen kit market is expected to grow in the near future owing to increasing demand for antigen kit in various application segments such as rapid medical diagnostics, in vitro diagnostic device, and molecular diagnostics. Increasing prevalence of liver diseases, autoimmune diseases, and sexually transmitted diseases are expected to propel the growth of the antigen market during the forecast period. According to the American Autoimmune Related Diseases Association (AARDA) currently 50 million people in the U.S. are living with autoimmune diseases. Autoantibody/autoantigen tests are used to diagnose autoimmune disorders. These are also used to evaluate the severity of the condition and monitor effectiveness of treatment and relapses of the disorders. Autoantibody tests are performed when a patient is suffering from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. According to the World Health Organization, around 203 million cases of malaria were reported worldwide in 2012. The disease accounted for nearly 627,000 deaths globally in the same year. Cross-reaction and false negative results are likely to hamper the growth of the market during the forecast period.
The global antigen kit market has been segmented based on technique, application, end-user, and region. In terms of technique, the market has been categorized into precipitation reaction, agglutination reaction, complement fixation, immunofluorescent assay, enzyme-linked immunosorbent assay (ELISA), and radioimmunoassay. Based on application, the market has been divided into tropical diseases, liver diseases, autoimmune diseases, and sexually transmitted diseases. End-users in this market include hospitals, diagnostics centers, clinics, and others.
Geographically, the global antigen kit market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest market for antigen kits due to increasing prevalence of autoimmune diseases and rising incidence of sexually transmitted diseases. According to the Centers for Disease Control and Prevention (CDC), nearly 20 million new sexually transmitted infections occur in the U.S. each year, half among young people aged 15 years to 24 years, and account for nearly US$ 16 Bn in health care costs. Europe was the second largest market for antigen kits owing to increasing incidence of liver diseases. According to the European Association for the Study of the Liver, in 2013, liver cirrhosis accounted for 170,000 deaths in Europe and nearly 63,500 new cases of liver cancer were diagnosed in Europe in 2012. Acceptance and demand for high-end medical infrastructure are the major factors driving the market in Asia Pacific. China, Japan, and India are the fast growing markets in the region and are projected to fuel market growth. Countries in Latin America such as Brazil and Mexico have significant potential owing to evolving medical structure and high disposable income.
Major players operating in the antigen kit market include Thermo Fisher Scientific, SD BIOSENSOR, Inc., SinoBiological, Inc., Cell Biolabs, Inc., Affinity Biologicals Inc., R-Biopharm AG, Epitope Diagnostics, Inc., and Oxford BioMedica.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.

To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29843

By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis
The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

Air-assisted Patient Transfer Systems Market Dynamics, Forecast, Analysis and Supply Demand -2025

Air-assisted patient transfer systems (AAPTS) are equipment used by caregivers to shift patients with impaired mobility between stretchers, beds, wheelchairs, shower benches, automobiles, commodes, toilets, chairs, swimming pools, and other patient support systems during procedures such as surgery, radiology, and other examinations. These devices are used to prevent immobility, work related injuries, life-threatening complications, and costly adverse events such as pressure ulcers and venous thromboembolism (VTE), patient falls, and health care associated infections such as pneumonia and urinary tract infections (UTI). Best example of reduced mobility can be seen among the critically ill patients prescribed to take complete bed rest for longer durations. This can have adverse health consequences as after one week the same patient may lose up to 20% muscle strength. Air-assisted patient transfer systems play an important role in such conditions while improving care environments across the globe by creating cultural change, reducing the risk of life-threatening unfavorable events, improving the lives of people affected by reduced mobility, maintaining the comfort and dignity of the patients and provide a safe and secure working environment for caregivers.

A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29840

The air-assisted patient transfer systems market has been segmented based on product type and end-user. Patients who are unable to move and cannot assist caregivers to move them completely depend on support hung from the ceiling or attached to the floor. Such devices are called patient lifts. Based on end-user, the market can be divided into hospitals, nursing homes, assisted living facilities, home health care, and others (trauma, rehabilitation & paramedical centers).
Rise in spinal cord injury cases among elderly people is a major factor driving the AAPTS market. Spinal cord injuries are common among men aged between 65 and 74, increasing from 84 cases per million to 131 cases per million over a 20-year period (recorded till 2012). Moreover, increase in bariatric patient population and rising number of back injuries and other related problems among sportsmen are factors propelling the market. However, competitive pricing faced by key manufacturers and limited adoption of these techniques by hospitals as some of these still rely on the traditional methods of patient transfer to keep costs low are the major restraints of the market. Rising opportunities in the market in terms of strategic alliances among key players, addition of new products with better functionality to achieve fewer musculoskeletal injuries among staff, reduction in compensation claims, less work days lost, direct medical expenses, and increased efficiency with fewer staff required to transfer patients are likely to augment the AAPTS market. For instance, in March 2017, HoverTech International, a leading manufacturer of air-assisted patient handling technologies, partnered with Sizewise, a global manufacturer of mobility devices and support surfaces, to expand its distribution network in the long term care market. In August 2017, HoverTech International introduced its new product Q2Roller, a lateral turning device for turning patient effortlessly without any manual lifting or pulling. Blue Chip Medical Products, Inc. recently launched a new air-based lateral transfer & repositioning system named ATM-AirPod. This device is available for multi-patient use and single-patient use.
Geographically, the air-assisted patient transfer system market has been divided into five regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the global market due to rising number of bariatric cases and increased pediatric and geriatric population. High awareness about providing safety to caregivers and working professionals is another factor driving the market in North America. Europe is the second largest market. Increased demand for providing complete assistance to patients with reduced mobility is one of the key factors driving the AAPTS market in developed countries in Europe such as the U.K., Germany, and France. Absence of legal and regulatory protocols in Asia Pacific pertaining to patient handling for patients as well as caregivers in developing countries such as India and Sri Lanka hampers the growth of the market. Increasing demand in countries such as Saudi Arabia and the UAE to keep health care facilities best in class boosts the market in the Middle East. Saudi Arabia has some of the best hospitals in the world. Affordability and lack of technology restrain the market in underdeveloped regions such as Africa and Latin America.
Key players operating in the air-assisted patient transfer systems market include ArjoHuntleigh (Getinge Group), AirPal, Inc., HoverTech International, Sage Products, and Blue Chip Medical Products, Inc.

To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29840


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Microneedle Drug Delivery System Market Analysis, Segments, Growth and Value Chain -2025

Microneedles are used for micro-projections of drugs. Microneedles are the pathways to biological membranes which can create transport pathways of micron dimensions for sampling body fluids, such as for measuring the blood glucose levels in diabetic therapy. Microneedle drug delivery system play an important role in pharmaceutical, biotechnology and medical industries. Array and microfabrication technologies are used extensively in medicine, biotechnology and pharmaceutica research. Microneedle drug delivery system promise pain-free delivery of both small and large molecular weight active pharmaceutical ingredients into the viable epidermis avoiding contact with nerve fibers and blood vessels present in the dermal layers. However, new developments in biotechnology, microfabrication technology, allow to demonstrate in vitro, ex vivo, and in vivo experiments, which is also paving the way for enhancement in the delivery of drugs.

A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30503

High adoption in number of safety issues that are emerging, which have short and long term implications for clinicians, patients, healthcare administrators, and regulators, growing research and development initiatives, growing demand for safer alternative to conventional hypodermic injections is the most important driving factor for microneedle drug delivery system market. According to the Centers for Disease Control and Prevention, new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases. Measles being a highly contagious virus can affect population in large number for which precautions during vaccine preparation and vaccination should be taken care. Around 20 million people are affected with measles every year and unfortunately, global coverage with the measles vaccine has been stagnant for the last few years at around 85% which is below the coverage percentage. Hence, microneedle patch are designed to administer by minimally trained workers and also to simplify storage, distribution, and disposal process. According to WHO, 2015, the number of cancer new cases is expected to rise by about 70% over the next 2 decades due to which there can be a demand of microneedle patches for the drug delivery system. Growth in technologies such as microneedle patches, rise in transdermal drug delivery applications for pain management, congestive heart failure and hormone replacement, will again fuel the overall microneedle drug delivery system market. Drug degradation, poor absorption, local irritation and variability in absorption is expected to hamper the microneedle drug delivery system market growth.
The microneedle drug delivery system market has been segmented by source type, by technology type, by application type, by end-users and by geography. In terms of technology type microneedle drug delivery system market is classified into hollow, porous, solid, and others. In terms of source type microneedle drug delivery system market is classified into silicon, metals, polymers, polysaccharides and others. In terms of application microneedle drug delivery system market is classified into cardiovascular, oncology, dermatology, neurology and others. Cardiovascular is highly growing application segment because of increasing prevalence of cardiovascular diseases and stroke globally. According to WHO, 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. In terms of end users microneedle drug delivery system market is classified into diagnostic laboratories, life sciences and research laboratories, hospitals, ambulatory surgical centers, and others.
Geographically microneedle drug delivery system market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically North America dominates the global microneedle drug delivery system market due to patient awareness with high per capita health care expenditure. Early-phase diagnosis and treatment of disease, and easy regulations for transdermal drug delivery vaccines is driving the medical biotechnology market which in turn is expected to drive the microneedle drug delivery system market in North America. Europe is the second largest market for microneedle drug delivery system as there are favorable government policies regarding health care infrastructure and awareness of contagious diseases. Asia Pacific is expected to grow at higher rate due to rising population, changing lifestyle, rising awareness between patients and increasing per capita expenditure. In addition, economic growth and improving the efficacy of cosmetic products is supporting the health care infrastructure improvement in developing countries such as India and China. Thus, all the above mentioned factors collectively support the growth of microneedle drug delivery system market for Asia Pacific region and expected to propel the market share of the segment by 2025.
The major players operating in the global microneedle drug delivery system include 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation, Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies, Innoture Medical Technology Limited, Phillips Plastic Corporation, Corium International, Inc., Stemedica Cell Technologies, Inc., and among others.

To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30503

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.